Topic BRAFV600E Mutation
-
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Dabrafenib Plus Trametinib Shows Promise in BRAFV600E-Mutated Rare Cancers
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0723Published: July 2023Expires: 6/30/2025Sources: Oncology TimesDetailsRequired Passing Score: 4/5 (80%)Categories: Hematology , OncologySpecialties: Hematology, OncologyTopics: BRAFV600E Mutation -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Dabrafenib Plus Trametinib Shows Promise in BRAFV600E-Mutated Rare Cancers ((Non-Physician Credit))
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OTN0723Published: July 2023Expires: 6/30/2025Sources: Oncology TimesDetailsRequired Passing Score: 4/5 (80%)Categories: Hematology , OncologySpecialties: Hematology, OncologyTopics: BRAFV600E Mutation